From Medical News Today:There is a large increased long-term risk of mortality in patients with
Alzheimer's disease (AD) who are prescribed antipsychotic medication....In total, 165 patients were randomised and of these, 128 started
treatment - 64 on antipsychotics, 64 on placebo. At 12 months, there
was 70% survival in the antipsychotic group compared with 77% in
placebo. However, longer term follow-up revealed bigger differences in
survival. At 2 years, survival was 46% in the antipsychotic group and
71% in the placebo group, and at 36 months the difference was even
greater: 30% antipsychotic versus 59% placebo. Overall, across the
whole study period, the risk of death was 42% lower in the placebo
group than in the antipsychotic group.... For More....
Alzheimer's disease (AD) who are prescribed antipsychotic medication....In total, 165 patients were randomised and of these, 128 started
treatment - 64 on antipsychotics, 64 on placebo. At 12 months, there
was 70% survival in the antipsychotic group compared with 77% in
placebo. However, longer term follow-up revealed bigger differences in
survival. At 2 years, survival was 46% in the antipsychotic group and
71% in the placebo group, and at 36 months the difference was even
greater: 30% antipsychotic versus 59% placebo. Overall, across the
whole study period, the risk of death was 42% lower in the placebo
group than in the antipsychotic group.... For More....
